Published in World J Surg Oncol on November 20, 2007
Retroperitoneal Castleman's disease: advocating a multidisciplinary approach for a rare clinical entity. World J Surg Oncol (2014) 0.79
Unicentric Castleman's Disease Masquerading Pancreatic Neoplasm. Case Rep Oncol Med (2012) 0.79
Pancreatic Castleman's Disease: Studies of Three Cases And A Cumulative Review of the Literature. Indian J Surg (2012) 0.77
Unicentric Castleman's disease approached as a pancreatic neoplasm: case report and review of literature. Cases J (2009) 0.77
Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer (1957) 9.27
Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer (1972) 7.70
Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood (1989) 4.17
The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer (1999) 2.90
A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol (1985) 2.67
Multicentric giant lymph node hyperplasia. Am J Clin Pathol (1978) 2.52
Castleman's disease and related disorders. Semin Diagn Pathol (1988) 2.47
Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest (1990) 2.37
Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS (1996) 2.28
Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med (1994) 2.13
Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol (1985) 1.79
Castleman's disease: more questions than answers. Hum Pathol (1985) 1.68
Angiofollicular lymph node hyperplasia (Castleman's disease). Cancer Treat Rev (1995) 1.55
Report of a case of localized Castleman's disease with progression to malignant lymphoma. Am J Clin Pathol (1992) 1.55
Expression of interleukin-6 in Castleman's disease. Hum Pathol (1993) 1.53
Angiomatous lymphoid hamartoma. Report of five cases with a review of the literature. Cancer (1967) 1.38
Interleukin-6 gene expression in Castleman's disease. Blood (1991) 1.37
A case of pseudolymphoma of the liver with chronic hepatitis C. J Hepatol (1997) 1.21
Remission of giant lymph node hyperplasia with anemia after radiotherapy. Cancer (1979) 1.16
Multicentric angiofollicular lymph node hyperplasia (Castleman's disease) followed by Kaposi's sarcoma in two homosexual males with the acquired immunodeficiency syndrome (AIDS). Am J Clin Pathol (1985) 1.00
Generalized lymphadenopathy with morphologic features of Castleman's disease in an HIV-positive man. Cancer (1987) 0.99
Development of vascular neoplasia in Castleman's disease. Report of seven cases. Am J Surg Pathol (1990) 0.96
Localized lymphoid hyperplasia (pseudolymphoma) of the pancreas presenting with obstructive jaundice. Hum Pathol (1991) 0.96
A case of localized Castleman's disease with systemic involvement: treatment and pathogenetic aspects. Ann Hematol (1996) 0.95
Angiofollicular lymph node hyperplasia (Castleman's disease) associated with vertebral destruction. Cancer (1985) 0.93
Multicentric giant follicular lymph node hyperplasia. Favorable response to radiotherapy. Cancer (1983) 0.92
Peripancreatic Castleman disease. JOP (2004) 0.91
Radiation therapy in the management of giant lymph node hyperplasia. Br J Radiol (1990) 0.90
Pseudolymphoma of the pancreas mimicking cancer. Pancreas (1994) 0.89
Angiofollicular lymph node hyperplasia (Castleman's disease) in an adolescent female. Clinical and immunologic findings. Cancer (1991) 0.89
Radiological presentations of Castleman's disease. Comput Med Imaging Graph (1993) 0.89
Multicentric Castleman disease and systemic lupus erythematosus phenotype in a boy with Klinefelter syndrome: long-term disease stabilization with interferon therapy. J Pediatr Hematol Oncol (2000) 0.87
Angiofollicular lymph node hyperplasia. Can Med Assoc J (1968) 0.86
Pancreatic Castleman disease simulating pancreatic carcinoma on computed tomography. J Comput Assist Tomogr (1982) 0.85
Castleman's tumor masquerading as a pancreatic neoplasm. Surgery (1989) 0.85
Castleman's disease: an unusual cause of a peri-pancreatic hilar mass. Aust N Z J Surg (1994) 0.85
Giant lymph node hyperplasia: a review of literature and report of two cases of plasma cell variant responding to radiation therapy. Int J Radiat Oncol Biol Phys (1979) 0.85
Interleukin-6. Cancer Invest (1993) 0.84
[Pancreatic Castleman's tumor revealed by prolonged fever]. Presse Med (1992) 0.81
Giant mediastinal lymph node hyperplasia (Castleman's disease): angiographic and clinical features. AJR Am J Roentgenol (1978) 0.81
Pancreatic localization of a Castleman's tumour. Acta Chir Belg (1994) 0.81
Unicentric Castleman's disease of the pancreas with massive central calcification. World J Gastroenterol (2005) 0.80
[Pancreatic localization of Castleman's tumor]. Gastroenterol Clin Biol (1999) 0.79
Angiography of angiomatous lymphoid hamartoma (Castleman tumor) and a suggested pathogenesis. Radiology (1979) 0.77
Progressive transformation of germinal center presenting with histological features of hyaline-vascular type of Castleman's disease. APMIS (2005) 0.76
Computed tomography of retroperitoneal castleman disease (plasma cell type) with sonographic and angiographic correlation. J Comput Assist Tomogr (1985) 0.76
Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol (2005) 4.79
Triage and outcome of patients with mediastinal penetrating trauma. Ann Thorac Surg (2007) 2.06
Sophorolipids block lethal effects of septic shock in rats in a cecal ligation and puncture model of experimental sepsis. Crit Care Med (2006) 1.77
B-type natriuretic peptide: a biomarker for the diagnosis and risk stratification of patients with septic shock. Arch Surg (2008) 1.59
Case report: Paenibacillus thiaminolyticus: a new cause of human infection, inducing bacteremia in a patient on hemodialysis. Ann Clin Lab Sci (2008) 1.57
Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients. J Gastrointest Surg (2003) 1.56
Assessment of Endoscope Reprocessing Using Peer-to-Peer Assessment Through a Clinical Community. Jt Comm J Qual Patient Saf (2016) 1.39
Image of the month--quiz case. Intussuscepted transverse colonic lipoma. Arch Surg (2007) 1.10
Surgical management of melanoma of the gallbladder: a report of 13 cases and review of the literature. Am J Surg (2007) 1.08
Prevalence of surgical conditions in individuals aged more than 50 years: a cluster-based household survey in Sierra Leone. World J Surg (2015) 1.05
Unknown primary. J Surg Oncol (2004) 1.04
Xenogeneic DNA immunization in melanoma models for minimal residual disease. J Surg Res (2002) 1.02
A Brief History of Pancreatic Reg: Implications as to its Clinical Importance. Einstein Q J Biol Med (2000) 0.99
Utility of desmin and a Masson's trichrome method to detect early acute myocardial infarction in autopsy tissues. Int J Clin Exp Pathol (2009) 0.89
Pancreatic reg I binds MKP-1 and regulates cyclin D in pancreatic-derived cells. J Surg Res (2008) 0.89
Closed claim review from a single carrier in New York: the real costs of malpractice in surgery and factors that determine outcomes. Am J Surg (2012) 0.88
The impact of frailty in the elderly on the outcome of surgery in the aged. Adv Surg (2010) 0.87
Pancreatic regenerating gene I and acinar cell differentiation: influence on cellular lineage. Pancreas (2009) 0.87
Approach to acute renal failure in biopsy proven myeloma cast nephropathy: is there still a role for plasmapheresis? Kidney Int (2008) 0.86
Implication of Reg I in human pancreatic duct-like cells in vivo in the pathological pancreas and in vitro during exocrine dedifferentiation. Pancreas (2004) 0.85
Pancreatitis-associated protein 2 modulates inflammatory responses in macrophages. J Immunol (2008) 0.85
Sophorolipids as antibacterial agents. Ann Clin Lab Sci (2009) 0.85
Sophorolipids and their derivatives are lethal against human pancreatic cancer cells. J Surg Res (2008) 0.84
Pancreatic regenerating protein (reg I) and reg I receptor mRNA are upregulated in rat pancreas after induction of acute pancreatitis. World J Gastroenterol (2006) 0.83
Vertebral venous air embolism: an unusual complication following colonoscopy: report of a case. Dis Colon Rectum (2003) 0.83
The penetratin sequence in the anticancer PNC-28 peptide causes tumor cell necrosis rather than apoptosis of human pancreatic cancer cells. Ann Surg Oncol (2008) 0.83
Pancreatic regenerating protein I in chronic pancreatitis and aging: implications for new therapeutic approaches to diabetes. Pancreas (2008) 0.83
Sophorolipids improve sepsis survival: effects of dosing and derivatives. J Surg Res (2007) 0.81
A knot in the heart. Am Surg (2008) 0.81
Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes. Proc Natl Acad Sci U S A (2010) 0.81
The anti-cancer peptide, PNC-27, induces tumor cell lysis as the intact peptide. Cancer Chemother Pharmacol (2010) 0.81
Pancreatic elastase is proven to be a mannose-binding protein--implications for the systemic response to pancreatitis. Surgery (2003) 0.81
Submucosal resection of giant gastric lipoma. J Surg Oncol (2006) 0.81
Small-interference RNA gene knockdown of pancreatitis-associated proteins in rat acute pancreatitis. Pancreas (2008) 0.81
Clinical Communities at Johns Hopkins Medicine: An Emerging Approach to Quality Improvement. Jt Comm J Qual Patient Saf (2015) 0.80
Colon cancer screening: where have we come from and where do we go? J Surg Oncol (2004) 0.80
Globalization of surgery: let's get serious. Arch Surg (2010) 0.79
Mutational characterization of pancreatitis-associated protein 2 domains involved in mediating cytokine secretion in macrophages and the NF-kappaB pathway. J Immunol (2008) 0.79
Patterns of recurrence of colorectal cancer. J Surg Oncol (2008) 0.79
Perforated appendicitis presenting as a thigh abscess. J Am Coll Surg (2008) 0.79
Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancer. Cancer Ther (2007) 0.78
AA-type amyloidosis associated with non-Hodgkin's lymphoma: a case report. Hum Pathol (2004) 0.78
Management of patients with metastatic cancer of unknown primary. Curr Probl Surg (2005) 0.78
Experience with dedicated geriatric surgical consult services: meeting the need for surgery in the frail elderly. Clin Interv Aging (2009) 0.77
Administration of anti-Reg I and anti-PAPII antibodies worsens pancreatitis. JOP (2009) 0.77
The role of lipopolysaccharide in T-cell responses following DNA vaccination. Vaccine (2003) 0.77
Pancreatitis-associated proteins' regulation of inflammation is correlated with their ability to aggregate. Pancreas (2011) 0.76
Modeling for the future: too many POSSUMS?: invited commentary on Pelavski, et al. Am J Surg 2013;205:58-63. Am J Surg (2013) 0.75
Less may be better: axillary dissection is unnecessary in some patients with a positive sentinel lymph node. Arch Surg (2011) 0.75
Acute pancreatitis in aging animals: loss of pancreatitis-associated protein protection? World J Gastroenterol (2012) 0.75
Transfusion in the elderly patient: keep your finger off the button? Ann Surg (2010) 0.75
Benefit of Radiotherapy in Extraskeletal Myxoid Chondrosarcoma: A Propensity Score Weighted Population-based Analysis of the SEER Database. Am J Clin Oncol (2016) 0.75
Massive bleeding from duodenal carcinoid treated by gastroduodenal artery embolization. J Surg Oncol (2002) 0.75
Incidental gallbladder carcinoma associated with a cholecystoduodenal fistula. Mil Med (2002) 0.75
Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy. Am J Clin Oncol (2017) 0.75
A proteasome inhibitor to treat acute pancreatitis? Maybe... J Surg Res (2009) 0.75
Computer graphic to design the approach for resection of esthesioneuroblastoma. J Surg Oncol (2002) 0.75
Breast cancer: from radical to minimal surgery. J Surg Oncol (2008) 0.75
Microcystic adenomas of the pancreas. J Am Coll Surg (2002) 0.75
Computerized tomogram to design surgery for removal of large Merkel cell carcinoma of the buttock preserving the function of the extremity. J Surg Oncol (2004) 0.75
Comparison of His and GST tagged versions of recombinant pancreatitis associated protein 2 in modulation of inflammatory responses. Inflamm Res (2010) 0.75
The role of the assistant in laparoscopic surgery: important considerations for the apprentice-in-training. Surg Innov (2008) 0.75